Regenxbio Inc banner

Wall St Price Targets

RGNX Price Forecast
Based on 13 analysts

+198% Upside
from $7.18 today

Regenxbio Inc (RGNX)’s 12-month stock price forecast through November 2027 has a consensus target of $21.42, implying 198% upside. The forecast is based on price targets from 13 Wall Street analysts.

RGNX Analyst Rating
Based on 11 analysts

avg. 4.55 of 5
Strong buy
7 64%
Buy
3 27%
Hold
1 9%
Sell
0 0%
Strong sell
0 0%

Analysts rate RGNX Strong buy, with 10 of 11 recommending Buy or Strong buy.

Regenxbio Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RGNX's stock price target?
Price Target
21.42 USD

According to Wall Street analysts, the average 1-year price target for RGNX is 21.42 USD with a low forecast of 12.12 USD and a high forecast of 52.5 USD.

What is the Revenue forecast for Regenxbio Inc?
Projected CAGR
29%

Over the last 11 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 29%.

What is the Gross Profit forecast for Regenxbio Inc?
Projected CAGR
28%

Over the last 11 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 8 years is 28%.

Back to Top